Cerebral ischemia: New risk factors

被引:21
作者
Diaz, J
Sempere, AP [1 ]
机构
[1] Hosp Vega Baja, S Neurol, ES-03314 Orihuela, Spain
[2] Hosp 12 Octubre, S Neurol, E-28041 Madrid, Spain
关键词
cerebral infarction; risk factors; infection; homocysteine; sleep apnea syndromes;
D O I
10.1159/000074794
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Stroke is a disease with well-defined modifiable risk factors such as arterial hypertension, smoking, diabetes, hyperlipidemia and atrial fibrillation. The need of new risk factors is based on the fact that only half the cardiovascular disease risk is explained by conventional risk factors. Inflammatory markers, infection, homocysteine and sleep-disordered breathing rank as the four most important new risk factors in cerebral atherosclerosis. C-reactive protein is the inflammatory marker that has been most thoroughly studied. Elevated concentrations of C-reactive protein increase the risk of heart disease and thromboembolic stroke in men and women. The role of Chlamydia pneumoniae is still controversial. Influenza vaccination is a simple and effective preventive measure against stroke. Despite the potential relationship between homocysteine and stroke, we should wait to the results of the ongoing trials to know if the reduction of homocysteine levels with vitamin therapy is of clinical benefit. Sleep-disordered breathing is a potential new risk factor with an effective therapy. Neurologists should not forget to look for sleep disorders in their stroke patients and probably manage them with breathing therapy from the acute phase. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 80 条
  • [11] Homocysteine and neurologic disease
    Diaz-Arrastia, R
    [J]. ARCHIVES OF NEUROLOGY, 2000, 57 (10) : 1422 - 1427
  • [12] DIMSDALE JE, 1995, SLEEP, V18, P377
  • [13] Influence of cholesterol on survival after stroke: Retrospective study
    Dyker, AG
    Weir, CJ
    Lees, KR
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7094): : 1584 - 1588
  • [14] Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
    Eikelboom, JW
    Lonn, E
    Genest, J
    Hankey, G
    Yusuf, S
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (05) : 363 - 375
  • [15] Chlamydia pneumoniae and the risk of first ischemic stroke -: The Northern Manhattan Stroke Study
    Elkind, MSV
    Lin, IF
    Grayston, JT
    Sacco, RL
    [J]. STROKE, 2000, 31 (07) : 1521 - 1525
  • [16] Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease -: A prospective study in middle-aged to elderly men with treated hypertension
    Fagerberg, B
    Gnarpe, J
    Gnarpe, H
    Agewall, S
    Wikstrand, J
    [J]. STROKE, 1999, 30 (02) : 299 - 305
  • [17] INTRACRANIAL HEMODYNAMICS IN SLEEP-APNEA
    FISCHER, AQ
    CHAUDHARY, BA
    TAORMINA, MA
    AKHTAR, B
    [J]. CHEST, 1992, 102 (05) : 1402 - 1406
  • [18] Giroud M., 1992, Neurological Research, V14, P315
  • [19] Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions results from a nested case-control study in northern Sweden
    Glader, CA
    Stegmayr, B
    Boman, J
    Stenlund, H
    Weinehall, L
    Hallmans, G
    Dahlén, GH
    [J]. STROKE, 1999, 30 (10) : 2013 - 2018
  • [20] GOLDSTEIN L, 2000, 25 INT STROK C NEW O